Table 2 Differences between distressed and not distressed subjects as measured at baseline (N=38)

From: Routine screening for psychosocial distress following hematopoietic stem cell transplantation

Baseline

N

Not distressed a (N=17, 45%)

N

Distressed (N=21, 55%)

P-value

Self-reported health status

 

N (%)

 

N (%)

 

 KPS ⩾80

15

12 (80%)

19

14 (74%)

1.0

 ‘Excellent’ or ‘very good’ health

15

10 (67%)

20

9 (45%)

0.31

SF36

 

Median (IQR)

 

Median (IQR)

 

 Physical composite scale

17

47 (37–51)

19

39 (28–49)

0.19

 Mental composite scale

17

57 (53–60)

19

42 (34–52)

<0.0001

Physical functioning

17

90 (60–95)

21

70 (45–80)

0.10

Social functioning

17

100 (75–100)

21

50 (38–75)

0.002

Vitality

17

70 (55–85)

21

35 (25–60)

0.0004

Role physical

17

75 (0–100)

20

25 (0–75)

0.14

Role emotional

17

100 (100–100)

21

33 (0–100)

0.002

Mental health

17

88 (80–92)

21

60 (48–72)

<0.0001

Pain

17

84 (74–100)

21

74 (41–100)

0.06

General health

17

67 (50–80)

20

60 (36–71)

0.20

FACT-BMT subscale

17

31 (29–35)

21

24 (19–26)

<0.0001

MOS Social support

 Overall

17

99 (96–100)

21

74 (66–87)

0.0006

 Affective

17

100 (100–100)

21

100 (75–100)

0.17

 Emotional

17

97 (97–100)

21

66 (50–81)

0.0001

 Social

17

100 (100–100)

21

92 (67–100)

0.01

 Tangible

17

100 (100–100)

21

88 (63–100)

0.01

Experience with psychosocial supports before transplantation

 

N (%)

 

N (%)

 

 Took a prescription drug for anxiety or depression

17

5 (29%)

21

15 (71%)

0.01

 Seen a psychologist or psychiatrist

17

1 (6%)

21

7 (33%)

0.05

 Seen a social worker

17

4 (24%)

21

15 (71%)

0.008

Follow-up (of those providing baseline assessments)

 Successfully screened

 

16 (94%)

 

16 (76%)

0.20

 Distressed in follow-up

 

2 (13%)

 

13 (81%)

<0.0001

  1. aWithin the normal range for depression (BDI) and anxiety (STAI).